Delivery Order SPE2DX22D0010-SPE2D826FBL61
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $6,545.30 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 potential value through December 2026. The delivery...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $171,685.92 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order represents a non-competitive award to the prime contractor and is performed at the company's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order falls under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,710.28 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The award was made through open competition with no...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $5,317.72 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 8, 2025, with an ultimate completion date of December 9, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor vehicle running through December 2026. The delivery order represents a...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $15,354.00 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $54,074.44 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $39,468.80 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 1, 2025, with completion due by December 2, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The award was made through...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $16,670.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 4, 2025, with completion scheduled for December 5, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $13,177.30 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The contract is being performed in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $17,642.84 firm fixed price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 8, 2025, with an ultimate completion date of December 9, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled at...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBL61Delivery Order
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,587.44 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999.99 million ceiling value extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal military and veteran healthcare systems, with performance of this delivery order taking place at the company's Conshohocken location. As one of the primary vendors under the DLA's Pharmaceutical Prime Vendor Global Program, AmerisourceBergen fulfills federal medical procurement requirements by supplying a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive federal contract portfolio demonstrates its capability to meet competitive procurement standards and support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order continues AmerisourceBergen's critical role in sustaining the medical supply chain for Department of Defense operations and beneficiaries worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 12/1/25 |